Back to the main directory
EarningsReview / Equity
- Valeo SE - Prudence pour le H2’25 by MidCap Partners
- Median Technologies - Succès de l’augmentation de capital by MidCap Partners
- JMT 2Q25: Group EBITDA/EBIT ahead, but in line Biedronka could limit outperformance by BNP Paribas Exane
- Positive read-x from Bio-Rad and llumina 2Q25 (QIA, BIM, SRT3) by BNP Paribas Exane
- INVEST SECURITIES - NEMETSCHEK : Surperformance T2 grâce aux contrats pluriannuels - NEUTRE, OC 120€ (vs 110€) by Invest Securities
- H1'25 Results - In line, IA set up to return to growth in H2 by BNP Paribas Exane
- H1’25 first take: EPS beat, OSG slightly soft, margins ahead; Consumer strong by BNP Paribas Exane
- GLEN, AAL, VALE by BNP Paribas Exane
- AXA: RDOS. 1S’25 (ANÁLISIS BANCO SABADELL) by Sabadell
- Median Technologies - Successful capital increase by MidCap Partners
- Poulaillon - Brief pause by MidCap Partners
- LATAM suppliers mulling whether to attempt August price hike, meanwhile Hardwood price trims to $495/T by BNP Paribas Exane
- Solid quarter but no update on liquidity by BNP Paribas Exane
- Q2'25 conf. call feedback by BNP Paribas Exane
- Non material data changes by BNP Paribas Exane
- Trump turns the screw on US pricing by BNP Paribas Exane
- H1 conf. call feedback by BNP Paribas Exane
- 华利集团（300979 CH） by HSBC
- Refining & Petchems: Pictures and profits by BNP Paribas Exane
- FQ2 postview: Earnings growth outlook turning lower by BNP Paribas Exane
- Engie 1H25 conference call key points & views by BNP Paribas Exane
- Time to Buy: 2Q highlights strong execution by BNP Paribas Exane
- H1’25: Off the call - Confident on the sustainability of Consumer growth by BNP Paribas Exane
- The Weekly Checkout by BNP Paribas Exane
- FQ4 Postview: Another year of ~20% EPS growth ahead by BNP Paribas Exane